LogicBio Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2017 to 2021

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
LogicBio Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2021.
  • LogicBio Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was -$31K, a 88.5% increase year-over-year.
  • LogicBio Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was -$654K, a 39.7% increase year-over-year.
  • LogicBio Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.07M, a 16.3% decline from 2020.
  • LogicBio Therapeutics, Inc. annual Nonoperating Income (Expense) for 2020 was -$922K, a 199% decline from 2019.
  • LogicBio Therapeutics, Inc. annual Nonoperating Income (Expense) for 2019 was $935K, a 129% increase from 2018.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$1.07M -$150K -16.3% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-04
2020 -$922K -$1.86M -199% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-04
2019 $935K +$527K +129% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-15
2018 $408K +$287K +237% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $121K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.